EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

INVESTIGATIVE RADIOLOGY, published by Lippincott Williams & Wilkins, is a premier peer-reviewed journal dedicated to disseminating innovative research in the fields of radiology, nuclear medicine, and imaging. With a notable impact factor underscored by its impressive ranking—10th out of 333 in its category, positioning it within the 97th percentile—this journal serves as a vital resource for researchers, professionals, and students eager to stay at the forefront of advancements from 1966 to 2024. Although it does not offer open access, the high-quality studies and reviews found within its pages contribute significantly to the understanding and application of modern imaging techniques. Recognized for its Q1 status in both miscellaneous medicine and radiology specializations, INVESTIGATIVE RADIOLOGY continues to play an essential role in shaping the future of diagnostic and therapeutic imaging.

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

RADIOGRAPHICS, published by the Radiological Society of North America (RSNA), is a premier academic journal dedicated to the field of radiology, nuclear medicine, and imaging. With an impressive impact factor and recognition in the top quartile (Q1) of both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging categories, RADIOGRAPHICS stands out as a leading platform for disseminating high-quality research and clinical findings. Since its inception in 1985 and projected to run until 2024, the journal has consistently provided essential insights into cutting-edge imaging techniques and advancements in radiological practices, making it invaluable for professionals, researchers, and students alike. Although it does not offer open access, the journal continues to flourish with a robust reputation, ranked 35th in its field according to Scopus, placing it within the 89th percentile of its category. With an unwavering commitment to enhancing the understanding and application of radiological sciences, RADIOGRAPHICS remains a pivotal resource for advancing knowledge and expertise within the medical community.

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.